Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
The Prostate|January 1, 1991
Effect of dimethylsulfoxide on the proliferation and glycosaminoglycan synthesis of rat prostate adenocarcinoma cells (PAIII) in vitro: isolation and characterization of DMSO-resistant cellsC R Kaneski, G Constantopoulos, R O BradyMutation Research|October 16, 2001
Mutation analysis of the acid beta-glucosidase gene in a patient with type 3 Gaucher disease and neutralizing antibody to algluceraseD P Germain, C R Kaneski, R O BradyProceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Mucolipidosis IV consists of one complementation groupE Goldin, A Cooney, C R Kaneski, et al.Neurology|December 13, 2006
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry diseaseC R Kaneski, D F Moore, M Ries, et al.Neurology|September 1, 1994
Pyridoxine-responsive hyper-beta-alaninemia associated with Cohen's syndromeJ J Higgins, C R Kaneski, I Bernardini, et al.Journal of Lipid Research|August 1, 1994
Hydrolysis of a novel lysosomotropic enzyme substrate for beta-galactosidase within intact cellsC R Kaneski, S A French, M R Brescia, et al.Journal of Inherited Metabolic Disease|January 1, 1994
Mucolipidosis IV fibroblasts synthesize normal amounts of hyaluronic acidE Goldin, Y Imai, C R Kaneski, et al.Journal of Inherited Metabolic Disease|January 27, 2005
Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher diseaseU H Schueler, T Kolter, C R Kaneski, et al.Neurobiology of Disease|December 18, 2003
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3U H Schueler, T Kolter, C R Kaneski, et al.Biochemical and Biophysical Research Communications|August 31, 1990
Type C Niemann-Pick disease: documentation of abnormal LDL processing in lymphocytesC E Argoff, C R Kaneski, E J Blanchette-Mackie, et al.Pageof 2